Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label whole-body PET/CT study for investigating the value of 68Ga NEB PET
imaging in the diagnosis and evaluation of lymphatic disorders including lymphedema,
lymphangioma, lymphangioleiomyomatosis, plastic bronchitis, lymphadenopathy caused by
rheumatoid arthritis, etc.